Christopher R. Reidy Transaction Report
2026-10-19SEC Filing 4 (0000785161-26-000223)
Christopher R. Reidy, a director at Encompass Health Corp, acquired 20 shares of common stock on October 15, 2026, valued at $0.0 per share. This acquisition was associated with dividend payments through restricted stock units. On October 19, 2026, Reidy acquired an additional 284 shares of common stock at a weighted average price of $126.89 per share, with individual transactions ranging from $126.83 to $126.89. These shares were purchased through the Directors Deferred Stock Investment Plan, funded by quarterly fee deferrals and reinvested dividends. Following these transactions, Reidy holds a total of 18,081 shares.